TSPAN32 and myeloid sarcoma: Next, we wanted to determine the expression of TSPAN32 in memory CD4+ T cells from HLA-DR4+ MS patients, following amplification by PHA and IL-2 and stimulation by irradiated autologous monocytes and DR4 myelin peptides.